Expression of concern
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
Paper Information
Record ID:
35178
Author(s):
Journal:
Publication Date:
March 17, 2021
Retraction Date:
January 24, 2022
(3.8 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Department of Gastroenterology, Klinikum Luneburg, University of Hamburg, Luneburg, Germany
- Department of Medicine, Division of Gastroenterology, Mater Dei Hospital, Msida, Malta cUniversity Hospital Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland, and Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois CHUV, University Hospital Lausanne, Lausanne, Switzerland
- Department of Gastroenterology and Hepatology, CHU UCL Namur, Yvoir, Belgium
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven,Leuven, Belgium, and Department of Chronic Diseases, Metabolism and Ageing,TARGID-IBD, KU Leuven, Leuven, Belgium
- Infectious Diseases Service, Centro Hospitalar Universitario Sao Joao, Porto, Portugal, and Instituto de Inovacao e Investigacao em Saude [I3s], Faculty of Medicine, Department of Medicine, University of Porto, Portugal
- Gastroenterology Department, St James University Hospital, Leeds, UK
- Humanitas Clinical and Research Center – IRCCS -, Rozzano [Mi], Italy, and Humanitas University, Department of Biomedical Sciences Milan, Italy
- Hospital Universitari Mutua Terrassa, Digestive Diseases Department, Terrassa, Catalonia, and Centro de Investigación Biomedica en red de Enfermedades Hepaticas y Digestivas CIBERehd, Madrid, Spain
- Inflammatory Bowel Disease Center, Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA
- Department of Gastroenterology, Barts Health NHS Trust, Royal London Hospital, London, UK
- Department of Gastroenterology, Venizeleio General Hospital, Heraklion, Greece
- Department of Gastroenterology, Sheba Medical Center, Ramat Gan, Israel, and Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
- Sorbonne Universite, INSERM, Institut Pierre Louis d’Epidemiologie et de Sante Publique, AP-HP, Hopital Saint- Antoine, Department of Gastroenterology, Paris, France
- Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
- Gastroenterology Department, Centro Hospitalar Sao Joao, Porto, Portugal, and Institute of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Portugal
- Outpatient Department of Gastroenterology, Department of Geriatrics, Klinikum Luneburg, University of Hamburg, Luneburg, Germany
- Department of Paediatric Gastroenterology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands
- IBD Unit, Department of Gastroenterology, Hospital Clinico San Carlos and Instituto de Investigacion del Hospital Clinico San Carlos [IdISSC], Madrid, Spain
- Ankara University School of Medicine, Department of Gastroenterology, Ankara, Turkey
- Centre Hospitalier de l’Universite de Montreal [CHUM] Pharmacy Department and Faculty of Pharmacy, University de Montreal, Montreal, QC, Canada
- University Hospital Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland
- Department of Infectious Diseases, Tourcoing Hospital, Tourcoing, France
Countries:
Article Type:
Publisher:
Oxford Academic
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1093/ecco-jcc/jjab227Additional Notes:
See also: https://doi.org/10.1093/ecco-jcc/jjab225 Journal was previously published by Elsevier until 2015.
Citations (338)
338
Total Citations307
Post-Retraction(90.8%)
30
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
2
Within 30 days
73
Within 1 year
156
After 2+ years
1254
Days since retraction (latest)
Antibiotics for inflammatory bowel disease: Current status
Daya Krishna Jha, Shubhra Mishra, Usha Dutta et al. (4 authors)
Indian Journal of Gastroenterology
Published: Feb 2024
9 citations
9 citations
738 days after retraction
Risk of tuberculosis with anti-TNF therapy in Indian patients with inflammatory bowel disease despite negative screening
Suprabhat Giri, Sukanya Bhrugumalla, Akash Shukla et al. (8 authors)
Arab Journal of Gastroenterology
Published: Feb 2024
2 citations
2 citations
738 days after retraction
Modern practical management of acute severe colitis
Alaa Abdelmeguid, Emma Whitehead, Shaji Sebastian
Indian Journal of Gastroenterology
Published: Feb 2024
5 citations
5 citations
738 days after retraction
The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review
Antonietta Gerarda Gravina, Raffaele Pellegrino, Alfonso Esposito et al. (9 authors)
Cancers
Open Access
Published: Jan 2024
16 citations
16 citations
737 days after retraction
SARS-CoV-2 vaccination in inflammatory bowel disease patients is not associated with flares: a retrospective single-centre Swiss study
Laura Rossier, Natalie Décosterd, Christoph Matter et al. (7 authors)
Annals of Medicine
Open Access
Published: Jan 2024
1 citation
1 citation
736 days after retraction
IMMUNE RESPONSE TO VACCINATION IN CHILDREN AND YOUNG PEOPLE WITH INFLAMMATORY BOWEL DISEASE: A 10 YEARS SYSTEMATIC REVIEW
Retna Gumilang
Journal of Advance Research in Medical & Health Science (ISSN 2208-2425)
Open Access
Published: Jan 2024
735 days after retraction
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients
Daniele Napolitano, Carlo Romano Settanni, L Parisio et al. (18 authors)
Indian Journal of Gastroenterology
Published: Jan 2024
6 citations
6 citations
726 days after retraction
The Networked Interaction between Probiotics and Intestine in Health and Disease: A Promising Success Story
Maria Skoufou, Christina Tsigalou, Stergios Vradelis et al. (4 authors)
Microorganisms
Open Access
Published: Jan 2024
17 citations
17 citations
724 days after retraction
Increasing ratio of opportunistic infections associated with sunshine exposure and economic level burdening Chinese inflammatory bowel disease hospitalized patients: the first nationwide survey from 2014 to 2019
Runing Zhou, Ruixian Wu, Li Wang et al. (4 authors)
BMC Public Health
Open Access
Published: Jan 2024
1 citation
1 citation
715 days after retraction
May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients’ questions? An evidence-controlled analysis
Antonietta Gerarda Gravina, Raffaele Pellegrino, Marina Cipullo et al. (9 authors)
World Journal of Gastroenterology
Open Access
Published: Jan 2024
36 citations
36 citations
712 days after retraction
Methanogenic Archaea in the Pediatric Inflammatory Bowel Disease in Relation to Disease Type and Activity
Agata Anna Cisek, Edyta Szymańska, Aldona Wierzbicka et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: Jan 2024
9 citations
9 citations
710 days after retraction
Cytomegalovirus Colitis in a Patient with Severe Treatment Refractory Ulcerative Colitis
Michelle Bao, Juliana M. Kennedy, Michael T. Dolinger et al. (6 authors)
Crohn s & Colitis 360
Open Access
Published: Jan 2024
4 citations
4 citations
707 days after retraction
Application of Artificial Intelligence Technology Based on Health and Medical Big Data in Disease Monitoring, Early Warning, and Prevention and Control
Chengwu Liu, Guanpei Ma, Desheng Huang
Procedia Computer Science
Open Access
Published: Jan 2024
1 citation
1 citation
707 days after retraction
Vaccine Knowledge and Awareness Among Patients with Chronic Inflammatory Diseases: Results from a Nordic Survey
Meliha C Kapetanovic, Randeep Mandla, Susanne Thiesen Gren et al. (11 authors)
Unknown Journal
Published: Jan 2024
707 days after retraction
Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative Colitis
David T. Rubin, Joana Torres, Miguel Regueiro et al. (11 authors)
Crohn s & Colitis 360
Open Access
Published: Jan 2024
4 citations
4 citations
707 days after retraction
Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea
Ji Eun Na, Sung Hoon Jung, Arum Choi et al. (5 authors)
Mycoses
Published: Jan 2024
1 citation
1 citation
707 days after retraction
Unravelling the cellular response to the SARS-COV-2 vaccine in inflammatory bowel disease patients on biologic drugs
Samuel J. Martínez‐Domínguez, Sandra G. García, Pilar Sainz‐Arnal et al. (18 authors)
Scientific Reports
Open Access
Published: Dec 2023
3 citations
3 citations
702 days after retraction
Cytomegalovirus Infection: An Underrated Target in Inflammatory Bowel Disease Treatment
Rossella Maresca, Simone Varca, Federica Di Vincenzo et al. (11 authors)
Journal of Clinical Medicine
Open Access
Published: Dec 2023
1 citation
1 citation
701 days after retraction
Tuberculosis infection in patients with inflammatory bowel diseases. Clinacal cases
Maria U. Timanovskaia, Yuliya R. Shaykhtdinova, Elena U. Zhulina et al. (7 authors)
Terapevticheskii arkhiv
Open Access
Published: Dec 2023
1 citation
1 citation
697 days after retraction
Emerging space for non-polyethene-glycol bowel preparations in inflammatory bowel disease-related colonoscopy: Veering toward better adherence and palatability
Raffaele Pellegrino, Antonietta Gerarda Gravina
World Journal of Gastroenterology
Open Access
Published: Dec 2023
5 citations
5 citations
683 days after retraction
Clinical validation of serum immunosignatures in early diagnosis of Crohn's disease
Xianzong Ma, Wenyu Zhang, Xin Wang et al. (13 authors)
iLABMED
Open Access
Published: Dec 2023
676 days after retraction
Attitude and influencing factors on exercise in patients with moderately to severely active inflammatory bowel disease: a qualitative study
Jing Wang, Shuping Tong, Yuehong Niu et al. (4 authors)
BMJ Open
Open Access
Published: Dec 2023
2 citations
2 citations
676 days after retraction
Role of Ustekinumab in Treatment of Ulcerative colitis: a Narrative Review
Mauro Grova, Alessandro Vitello, Mariella Mannino et al. (7 authors)
Immunotherapy
Published: Nov 2023
1 citation
1 citation
674 days after retraction
Monitoring of Inflammatory Bowel Disease in Pregnancy: A Review of the Different Modalities
Reem Al-Jabri, Panu Wetwittayakhlang, Péter L. Lakatos
Journal of Clinical Medicine
Open Access
Published: Nov 2023
4 citations
4 citations
672 days after retraction
Author's reply: “Tofacitinib in ulcerative colitis—Small molecule but large effect”
Fabio Salvatore Macaluso, Ambrogio Orlando
Digestive and Liver Disease
Published: Nov 2023
670 days after retraction
A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study)
Diego Casas Deza, Ana Belén Julián Gomara, Eva Caudevilla Biota et al. (35 authors)
Gastroenterología y Hepatología
Published: Nov 2023
668 days after retraction
A pilot study of the use of the oral and faecal microbiota for the diagnosis of ulcerative colitis and Crohn's disease in a paediatric population
Toni Monleón-Getino, Gemma Pujol‐Muncunill, Javier Méndez Viera et al. (7 authors)
Frontiers in Pediatrics
Open Access
Published: Nov 2023
3 citations
3 citations
661 days after retraction
Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus
Sameer Al Awadhi, Mohamed Alboraie, Emad Aldin M. Albaba et al. (16 authors)
Journal of Clinical Medicine
Open Access
Published: Nov 2023
5 citations
5 citations
649 days after retraction
Histologic Activity in Inflammatory Bowel Disease and Risk of Serious Infections: A Nationwide Study
Karl Mårild, Jonas Söderling, Jordan E. Axelrad et al. (21 authors)
Clinical Gastroenterology and Hepatology
Open Access
Published: Oct 2023
12 citations
12 citations
644 days after retraction
Risk Factors of <i>Pneumocystis jirovecii</i> Pneumonia in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study
Jiyoung Yoon, Seung Wook Hong, Kyungdo Han et al. (10 authors)
Gut and Liver
Open Access
Published: Oct 2023
3 citations
3 citations
637 days after retraction
Attitudes towards Vaccinations in a National Italian Cohort of Patients with Inflammatory Bowel Disease
Andrea Costantino, Marco Michelon, Daniele Noviello et al. (9 authors)
Vaccines
Open Access
Published: Oct 2023
3 citations
3 citations
627 days after retraction
Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections
Carolina Aliai Micol Cavalli, Roberto Gabbiadini, Arianna Dal Buono et al. (10 authors)
Journal of Clinical Medicine
Open Access
Published: Oct 2023
13 citations
13 citations
623 days after retraction
Safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease
Albert Martín‐Cardona, Diana Horta, P Flórez-Díez et al. (27 authors)
Digestive and Liver Disease
Published: Sep 2023
610 days after retraction
Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE
Stefan Schreiber, Gerhard Rogler, Mamoru Watanabe et al. (15 authors)
Alimentary Pharmacology & Therapeutics
Open Access
Published: Sep 2023
9 citations
9 citations
602 days after retraction
Tofacitinib in Steroid-Refractory Acute Severe Ulcerative Colitis: A Retrospective Analysis
Sayan Malakar, Srikanth Kothalkar, Umair Shamsul Hoda et al. (4 authors)
Cureus
Open Access
Published: Sep 2023
8 citations
8 citations
601 days after retraction
Budesonide, an anti-inflammatory drug, exacerbate clostridioides difficile colitis in mice
Qianyun Lin, Zitong Li, Lei Lü et al. (13 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Sep 2023
2 citations
2 citations
599 days after retraction
Adherence to Recommended Immunization Schedules in Patients with Inflammatory Bowel Disease on Biologics and Small Molecule Therapies
Mohammad Shehab, Ranim AlMatar, Rawan Almohammad et al. (4 authors)
Gastroenterology Insights
Open Access
Published: Sep 2023
1 citation
1 citation
598 days after retraction
JAK inhibitors for inflammatory bowel disease: recent advances
Sailish Honap, Alexandra Agorogianni, Michael Colwill et al. (8 authors)
Frontline Gastroenterology
Open Access
Published: Sep 2023
45 citations
45 citations
598 days after retraction
Vedolizumab as Rescue Therapy in Carboplatin-Gemcitabine-Induced Triggered Acute Severe Ulcerative Colitis Flare-Up
Raffaele Pellegrino, Morena Fasano, Floriana Morgillo et al. (12 authors)
Gastrointestinal Disorders
Open Access
Published: Sep 2023
2 citations
2 citations
585 days after retraction
Cytomegalovirus Pneumonia in Inflammatory Bowel Disease: Literature Review and Clinical Recommendations
Keyu Ren, Chunming Yong, Yanting Wang et al. (9 authors)
Infection and Drug Resistance
Open Access
Published: Sep 2023
4 citations
4 citations
585 days after retraction
Clinical guidelines. Crohn’s disease (К50), adults
Yu. A. Shelygin, В. Т. Ивашкин, С. И. Ачкасов et al. (65 authors)
Koloproktologia
Open Access
Published: Aug 2023
28 citations
28 citations
581 days after retraction
Tissue quantitative RT–PCR test for diagnostic significance of cytomegalovirus infection in patients with inflammatory bowel disease and treatment response: Cytomegalovirus infection in patients with inflammatory bowel disease
Burcu Özdemir, Ali Atay, Meral Akdoğan et al. (7 authors)
Medicine
Open Access
Published: Aug 2023
1 citation
1 citation
557 days after retraction
Prevalence of Disease-Related Malnutrition and Micronutrients Deficit in Patients with Inflammatory Bowel Disease: A Multicentric Cross-Sectional Study by the GSMII (Inflammatory Bowel Disease Study Group)
Chiara Viganò, Andrea Palermo, Giacomo Mulinacci et al. (24 authors)
Inflammatory Bowel Diseases
Published: Aug 2023
10 citations
10 citations
556 days after retraction
Diagnosis, management, and prevention of infectious complications in inflammatory bowel disease: variations among Asian countries
Ji Eun Baek, Sung Wook Hwang
Intestinal Research
Open Access
Published: Jul 2023
550 days after retraction
Beyond the survey, to the ideal therapy for Asian
Ki Jae Jo, Jong Pil Im
Intestinal Research
Open Access
Published: Jul 2023
550 days after retraction
Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
Yu Kyung Jun, Seong‐Joon Koh, Dae‐Seong Myung et al. (7 authors)
Intestinal Research
Open Access
Published: Jul 2023
6 citations
6 citations
550 days after retraction
SARS-CoV-2 vaccination in inflammatory bowel disease (IBD) patients – does treatment for IBD negatively affect SARS-CoV-2 antibodies? A single-centre, prospective study
Katarzyna Karłowicz, Konrad Lewandowski, Edyta Tulewicz-Marti et al. (9 authors)
Gastroenterology Review
Open Access
Published: Jul 2023
549 days after retraction
Spanish Society of Primary Care Physicians (SEMERGEN) and Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) survey on the management of patients with inflammatory bowel disease
Daniel Ginard, Mercedes Ricote, Pilar Nos et al. (8 authors)
Gastroenterología y Hepatología (English Edition)
Open Access
Published: Jul 2023
546 days after retraction
The safety of vedolizumab in a patient with Crohn’s disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report
Yuya Sugiyama, Nobuhiro Ueno, Shion Tachibana et al. (14 authors)
Medicine
Open Access
Published: Jul 2023
3 citations
3 citations
536 days after retraction
Effects of Continuous Nursing on the Disease Uncertainty, Coping Strategies and Quality of Sleep and Life of Patients with Inflammatory Bowel Disease
Chongwu Xu, Weizhen Xi, Chen Wu et al. (5 authors)
Journal of Multidisciplinary Healthcare
Open Access
Published: Jul 2023
3 citations
3 citations
523 days after retraction
Quick Stats
Total Citations:
338
Years Since Retraction:
3.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025